Anticoagulation in Stent Intervention "MUSICA-2"

Active, not recruiting

Phase 4 Results N/A

Summary of Purpose

Objective: The main objective is to evaluate the pattern of dual antiplatelet therapy (aspirin, 300 mg / day + clopidogrel 75 mg / day) compared to the use of the triple regimen (Acenocoumarol as control + acetylsalicylic acid 100 mg / day + Clopidogrel 75 mg / day) in patients with atrial fibrillation, low-moderate risk of stroke (CHADS ≤ 2) who are undergoing PCI-S. Design: Randomized, parallel,...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 23 February 2015.

1 Jun 2010 9 Jun 2010 1 Dec 2015 1 Dec 2015 1 Feb 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Single Blind (Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts